Navigation Links
Overdose deaths down 35 percent after opening of Vancouver's supervised injection site: UBC-BC-CfE study
Date:4/18/2011

Illicit drug overdose deaths in Vancouver's Downtown Eastside dropped by 35 per cent after the establishment of Insite, North America's first supervised injection facility, according a new study by researchers at the University of British Columbia and the British Columbia Centre for Excellence in HIV/AIDS.

Published today in The Lancet, the study is the first to assess the impact of supervised injection sites on overdose mortality. Researchers compared nearly 300 case reports from the British Columbia Coroners Service documenting all illicit drug overdose deaths in Vancouver between January 1, 2001 and December 31, 2005.

Compared to the 35 per cent reduction in overdose deaths in the immediate vicinity of Insite following its opening in September 2003, overdose deaths in the rest of Vancouver declined only nine per cent over the same period. No overdose deaths have been recorded at Insite since the facility's opening. The researchers also noted that there was no evidence of significant changes in drug supply or purity during the study period.

"This study provides the first unequivocal scientific evidence of the benefits of supervised injection facilities, and clearly demonstrates that facilities such as Insite are saving lives and playing a vital role in reducing the harms associated with illicit drug use," says co-author Dr. Julio Montaner, director of the BC-CfE and Chair of AIDS Research at the UBC Faculty of Medicine.

"Research results clearly show facilities such as Insite could literally be the difference between life and death for many people," says senior author Dr. Thomas Kerr, an associate professor at UBC and co-director of the Urban Health Research Initiative (UHRI), a program of the BC-CfE.

Insite is a pilot facility with 12 injection seats in a neighbourhood with an estimated 5,000 injection drug users. Currently operating at capacity, Insite staff supervise more than 500 injections on an average day. Larger reductions in overdose deaths would require an expansion of the facility.

Established in 2003 in response to an HIV epidemic and escalating overdose death rates in Vancouver's Downtown Eastside, Insite enables injection drug users to consume pre-obtained drugs under the supervision of nurses. Counsellors are also available onsite to provide support and referrals to programs, including addiction treatment. An extensive scientific evaluation by UHRI researchers has previously demonstrated the facility's ability to reduce HIV risk behaviour, increase access to addiction treatment and primary health care services, and reduce healthcare costs in the long term.

On January 15, 2010, the BC Court of Appeal upheld a decision by the BC Supreme Court and ruled that Insite, a health care facility, is under provincial jurisdiction. An earlier BC Supreme Court decision also ruled that Insite helped ensure the constitutional right to health by providing an essential health service.

The federal government has submitted an appeal to the Supreme Court of Canada. The case is scheduled to be heard on May 12, 2011. Several groups and organizations, including the Canadian Medical Association, the Canadian Public Health Association, and the Canadian Nurses Association have obtained intervener status in the upcoming Supreme Court of Canada case, and will be calling for the continued operation of Insite.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related medicine news :

1. Kids Could Overdose From Nicotine-Laced Candy
2. Violence, not overdose, the likely method of suicide in veterans with substance use disorders
3. Pine Nut Oil - Natural Remedy for Radiation Overdose
4. New program targets research on reducing deaths due to prescription opioid overdose
5. Patients on Higher Doses of Prescription Painkillers More Apt to Overdose
6. Most maternal deaths in sub-Saharan Africa could be avoided
7. As Temperatures Rise, So Do Cocaine Deaths
8. PSA Test Reduces Prostate Cancer Deaths by 40%
9. Fewer Deaths in Larger, Busier Hospitals
10. Grassroots Campaign Drives toward Ending Malaria Deaths by 2015
11. New Research Shows 'Kangaroo Mother Care' Reduces Newborn Deaths More than 50 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the body ... with its product now available through Jet.com. , After 25 years of development, ... drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery ... Diane Winters. Diane is from Southwest Nebraska where she was raised on a ... family. The story is fictional, but the friendships and mantra of ‘neighbors helping ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... marketers of high-quality anti-aging skincare solutions, recently announced the launch of ... products are an affordable, yet effective alternative to expensive plastic surgery or in-patient ...
(Date:8/18/2017)... ... 2017 , ... “Case #10-5411 Veterans Administration”: a personal account ... #10-5411 Veterans Administration” is the creation of published author, Carol Mulhern, single mother ... Mulhem started work at the Coatesville VAMC as a file clerk then later ...
(Date:8/17/2017)... ... August 17, 2017 , ... When Amy Cowperthwait ... nurse, she took with her a dream to make nursing education more relevant and ... ensuring communication skills were integrated into healthcare provider education. , “The human ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
(Date:8/2/2017)... -- CaryRx, a next-generation full-service pharmacy, has announced the launch ... the Washington D.C. metropolitan area. CaryRx ... of medications through the convenience of its patient-friendly mobile app. ... one hour to any location in D.C. ... service to Washington D.C. ," says Areo ...
Breaking Medicine Technology: